Longevity Today
Academic PapersReviewsVideosPodcastsPress ReleasesClinical TrialsDrug ApprovalsTutorialsAnimations
All Articles
Sign In
Deep Dive Audio
Blocking NRF1 Slows Cellular Aging and Extends Lifespan in MiceLongevity & Aging

Blocking NRF1 Slows Cellular Aging and Extends Lifespan in Mice

Researchers at Nankai University discovered that the transcription factor NRF1 orchestrates the chronic inflammation tied to aging — called inflammaging — by switching on key innate immune genes TBK1 and IRF3. When cells sustain DNA damage, the enzyme ATM phosphorylates NRF1 at a specific site (Ser393), amplifying inflammatory signaling and accelerating cellular senescence. Knocking down NRF1 in mouse fibroblasts reduced senescence markers, cut inflammatory secretions, and restored cell-cycle activity. In aged mice, NRF1 knockdown treatment reduced signs of organ aging and meaningfully extended lifespan. The findings position NRF1 as a druggable target that could suppress the senescence-associated secretory phenotype (SASP) without the off-target tissue damage seen with current senolytic drugs.

Deep Dive Audio
0:00--:--
Read Full Article
Longevity Today

Developed by the Clinical and Foundational Medicine Institute

AI-powered summaries of the world's best longevity research — from peer-reviewed journals to expert podcasts and YouTube deep-dives. Built for those who take their healthspan seriously.

info@LongevityToday.com

Categories

CancerHeart DiseaseAlzheimer'sParkinson'sDiabetesGut HealthNutritionStrength & FitnessSupplements & PeptidesStem CellsReversing AgingAuto-ImmunityAdvanced Therapies

Platform

  • All Articles
  • Membership Plans
  • Search
  • Newsletter

Newsletter

Weekly longevity research, summarized.

Enter your email to subscribe:

© 2026 Longevity Today. All rights reserved.

About UsPrivacy PolicyTerms of UseMedical Disclaimer

Content on Longevity Today is for informational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before making health decisions.